Chairman, President & CEO, LabCorp
Leadership Committee

Global business leader, Adam H. Schechter, became chief executive officer of LabCorp (NYSE: LH) on Nov. 1, 2019, and chairman on May 13, 2020. Prior to that, Schechter was named lead independent director in January 2019 after serving on the board since 2013. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostics solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care.

A highly respected healthcare executive with a deep understanding of the U.S. and global environments, Schechter joined LabCorp after a long and distinguished career at Merck, where he served as executive vice president and president of global human health, and was a member of the executive committee. At Merck, among other accomplishments, Schechter focused on ensuring that Merck’s medicines and vaccines were available to people around the world; led a large global organization across the spectrum of commercial operations; transformed Merck’s commercial model; and led the integration of Merck and Schering-Plough. He held a number of professional, managerial, and executive roles with the company. Prior to his most recent role from 2010 to 2018 as president of global human health, Merck’s global pharmaceuticals and vaccines business, Schechter served as president of the global pharmaceutical business from 2007 to 2010. Before that, he led Merck’s U.S. pharmaceutical business. He began his career with Merck in 1988 as a sales representative.

Schechter, 56, is the board chair for Water.org and an executive board member for the National Alliance for Hispanic Health. He holds a Bachelor of Arts in biology from La Salle University. Previously, he served on the boards of the European Federation of Pharmaceutical Industries and Associations (EFPIA), where he led the Policy and Access Committee, the Healthcare Leadership Council, and the Merial Animal Health Company.

As a leading global life sciences company, LabCorp is the world’s largest clinical and diagnostics laboratory, with scientific expertise in esoteric testing, companion diagnostics, and clinical and anatomic pathology, and provides end-to-end drug and device development services from early-stage research to clinical trial management and beyond. LabCorp conducts business in more than 100 countries, has nearly 65,000 employees worldwide, and generated more than $11.5 billion in revenue in 2019. It has been named to Fortune’s List of World’s Most Admired Companies, earned the designation as a Best Place to Work for LGBTQ Equality by the Human Rights Campaign Foundation, and was named to Forbes’ ranking of The World’s Most Innovative Companies.